This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Erich Koller, Ph.D.
Senior Principal Scientist at Roche Innovation Center Basel
Speaker

Profile

Erich Koller is a DMPK-PD project leader in the translational PKPD and clinical pharmacology chapter at F. Hoffmann-La Roche in Basel, Switzerland where he is focusing on pharmacokinetics of antisense oligonucleotides and large molecules. Before this, he worked at Ionis Pharmaceuticals in Carlsbad, California as an Assistant Director where he studied the mechanism of ASO uptake, performed preclinical studies of ASO and did mechanistic studies with siRNA. Previously, he worked at Ionis Pharmaceuticals as a Postdoctoral Fellow looking at ASOs modulating NF-kB and JNK signaling pathways. Prior to this he was a postdoctoral Fellow at the Sanford Burnham Prebys in La Jolla, California where he studied cadherin cell adhesion molecules using molecular and cellular biology techniques. He has a PhD in Biochemistry from the Federal Institute of technology (ETH Zürich) Switzerland and obtained his BS in biochemistry from the ETH in Zürich. Erich has years of experience in the field of antisense oligonucleotides and large molecules.

Agenda Sessions

  • Clinical Update on Rugonersen

    10:45
  • Increasing ASO Stability with Chemical Modifications

    14:30